Apollo Hospitals Enterprise Limited vs Krebs Biochemicals and Industries Limited
A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Krebs Biochemicals and Industries Limited (KREBSBIO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs KREBSBIO on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth10
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
- − ["Stock is trading at 11.97 times its book value"]
- + []
- − ["The company has delivered a poor sales growth of -15.2% over past five years.", "Company reported a net loss of ₹17 Cr in its latest financial year."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.